InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Kelly Michael Aaron, Director. Officer active across 4 companies, notably DMC Global Inc.. Cumulatively, 19 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €34k. Activity tracked since 12 May 2021. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Kelly Michael Aaron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
16,937 股0Common StockSEC:0001769668-26-000002:0
72,468 股@ US$14.500.022% mcap100.0% 占其流量Common StockSEC:0001193125-26-182271:0
20,414 股0Common StockSEC:0000950170-25-083218:0
12,254 股0Common StockSEC:0001077183-25-000128:0
5,000 股@ US$7.60100.0% 占其流量Common StockSEC:0001077183-25-000112:0
标准退出：2025年8月25日 (T+90)
17,580 股0Common StockSEC:0000034067-25-000104:0
5,518 股0Common StockSEC:0000034067-25-000034:0
11,336 股0Common StockSEC:0001077183-24-000131:0
11,847 股0Common StockSEC:0000950170-24-071005:0
9,520 股0Common StockSEC:0000034067-24-000085:0
8,584 股0Common StockSEC:0001209191-23-036429:0
7,086 股0Common StockSEC:0000034067-23-000097:0
15,556 股0Common StockSEC:0001077183-22-000113:0
12,671 股0Common StockSEC:0001209191-22-035831:0
5,006 股0Common StockSEC:0000034067-22-000076:0
4,610 股0Common StockSEC:0001567619-21-012874:0
10,115 股0Common StockSEC:0001209191-21-040387:0
3,081 股0Common StockSEC:0001077183-21-000161:0
1,888 股0Common StockSEC:0000034067-21-000077:0
19 条申报中的 19 条
About Kelly Michael Aaron
Michael Aaron Kelly is a Director at DMC Global Inc., Neogenomics Inc., and Amicus Therapeutics, Inc. In this role, he participates in strategic decision-making and the direction of operations for these companies. Kelly brings his expertise to guide growth and innovation initiatives, thereby contributing to the success of each organization.
